AGP Executive Report

Sweden Election Watch: Sweden heads to a knife-edge vote on Sunday, with polls tightening and the far-right Sweden Democrats potentially gaining ministerial posts for the first time—an outcome that could reshape welfare, crime policy, and immigration. Mental Health & Women’s Health: A Swedish study reports escitalopram during the luteal phase can ease symptoms of premenstrual dysphoric disorder, especially irritability and anger. Public Health Policy Debate: Sweden’s tobacco-control approach is again in the spotlight as the government faces criticism over nicotine pouches and snus, with the Public Health Agency saying there’s no clear proof they drove recent declines in smoking. Healthcare & Society: Coverage also flags broader healthcare concerns tied to Sweden’s migration stance as the election campaign turns increasingly focused on welfare and security. EU Circular Economy: EU plans for a Circular Economy Act aim to harmonise waste rules and speed up recovery of critical materials from waste—relevant for health via cleaner supply chains and reduced import dependence.

Healthcare at the ballot box: Sweden’s election is being framed as a healthcare test, with parties promising fixes for long waits and staffing strain, while clinicians warn reforms may miss the real need: stronger primary care and better working conditions. ADHD & gut health: A major review of 1.9 million people links ADHD with higher rates of digestive problems, including constipation, IBS, and loss of bowel control—fueling interest in the gut-brain connection. Cancer risk & family history: A Swedish register study finds colorectal cancer risk rises even for people without IBD if they have close relatives with CRC, with the biggest jump when two or more first-degree relatives are affected. Prostate screening expansion: Nuffield Health and Prostate Cancer Research are launching a large screening study, aiming to test and improve early detection for thousands of men. Life science momentum in Sweden: Nordic Life Science Days in Stockholm highlights growing investor interest and major licensing activity, underscoring Sweden’s push to turn biotech into faster patient impact. Public health in focus: World Suicide Prevention Day coverage spotlights renewed tools to strengthen suicide prevention efforts.

ADHD & Gut Health: A major review of 1.9 million people links ADHD with a sharp rise in gastrointestinal problems, including constipation, IBS and loss of bowel control—an issue that can be missed when care focuses only on attention and behavior. Sweden Election Watch: In the final televised debate ahead of Sweden’s 13 September general election, party leaders clashed over housing costs, jobs, schools and climate policy, with the far-right Sweden Democrats pressing for tougher stances on immigration. Procurement Rules Under Scrutiny: A Swedish watchdog warns EU public procurement reforms may improve quality scoring, but still fall short on making human-rights and environmental safeguards mandatory—raising concerns about unfair contract wins. Healthcare Screening in Focus: Nuffield Health and Prostate Cancer Research are launching a large UK study using the Stockholm3 blood test to improve early prostate cancer detection, aiming to feed into real-world clinical pathways. Migration Pressure on Health & Safety: Coverage highlights Sweden’s tightening immigration approach and the human fallout for vulnerable people, including deportation decisions affecting families with serious health needs. Global Health & Safety: A school fire in rebel-controlled Bukavu, eastern Congo, killed at least 17 children, with reports suggesting the death toll may rise.

Sweden Election & Healthcare: A Swedish surgeon warns election promises on healthcare “don’t add up,” as staffing and training gaps keep widening and doctors say the focus on primary care misses the bigger implementation problem. Migration & Care Capacity: Sweden’s tighter migration stance is raising alarms inside hospitals, where many specialist staff and nursing assistants are foreign-born and operations depend on that workforce. Diabetes Safety: A major Scandinavian study finds ketoacidosis risk with SGLT2 inhibitors stays elevated beyond the start of treatment, with higher risk linked to patient factors—so clinicians should assess risk throughout. Obesity Drug Watch: Novo Nordisk says Wegovy is approved in China for MASH, extending GLP-1 use beyond weight and heart benefits into liver health. Cancer Screening Attention: Jeremy Clarkson’s prostate cancer story keeps spotlighting Stockholm3 testing, with renewed calls for broader access to more effective screening. Public Health Context: Sweden’s election also plays out amid broader concerns about social cohesion and trust, with Malmö’s integration debate front and center.

MS Treatment Update: A Karolinska Institutet-led study of newly diagnosed MS patients found early B-cell–depleting therapies were linked to fewer relapses and fewer MRI lesions than oral options, but disability scores looked similar after two years—so benefits may show up in disease activity more than day-to-day function. New Drug Push in Sweden: Sobi (Swedish Orphan Biovitrum) says the US FDA granted Fast Track to pacritinib for VEXAS syndrome, aiming to speed development for a rare, serious inflammatory condition. Wearables for Heart Health: Apple unveiled Apple Watch Series 12 and Watch Ultra 4 with a new Health Sensing System for higher-frequency heart rate and HRV, plus a readiness score and a Health Age “Longevity” feature. Cancer Research in Space: Swedish-linked space plans include launching human cancer cells from Australia to Sweden for microgravity testing, hoping to reveal how tumors behave under stress. Public Health & Policy: Sweden’s election race is tightening, with welfare and security front and center—an issue that can shape healthcare priorities. Food Safety: The EU’s PFAS limits for food-contact packaging now apply, with Sweden also moving toward broader PFAS restrictions.

Cardiovascular risk in autoimmune disease: A Swedish register study finds people with ANCA-associated vasculitides face higher cardiovascular and clotting risks, with men and women showing different patterns for heart attack vs stroke. Suicide prevention data: Sweden’s official 2025 suicide statistics are now published by county, with further breakdowns (methods, trends, self-harm) still to come. Prostate screening push: Britain’s Stockholm3 blood test is being offered to up to 10,000 men (ages 45–74), aiming to catch more aggressive prostate cancers earlier. Migration and healthcare pressure: Sweden is offering foreign-born residents $37,000 to leave as election pressure grows, raising concerns about impacts on health and welfare services. World Suicide Prevention Day: September 10 highlights “Hope is the Path to Survival” and urges people to start the conversation. Logistics update: China Eastern resumes cargo flights to Stockholm and has chosen WFS for handling, including new pharma-capable facilities. Heat & antibiotic resistance: A European study suggests heatwaves can temporarily reduce antibiotic resistance gene production in soil bacteria, even as extreme weather damages ecosystems.

UK–France–Canada Settlement Trade Ban: Britain, France and Canada announced bans on imports from Israeli West Bank settlements, accusing Israel of “ethnic cleansing” amid rising settler violence; Israel retaliated by targeting UK diplomatic access. Sweden Research & Health Tech: EuroHPC and NAISS inaugurated the Arrhenius supercomputer in Sweden, aimed at boosting work in life sciences and drug discovery. Severe Asthma Brain Links (Sweden): New Karolinska Institutet research links severe type-2 asthma to brain structural changes, suggesting inflammation may extend beyond airways. Cluster Headache Causes: Swedish studies point to genetics, inflammation and tobacco smoke exposure as contributors to cluster headaches, the “suicide headache.” Obstetric Fistula Care Gap: A report highlights the long wait for fistula surgery in Liberia and the devastating impact of delayed treatment. Public Health Data Transparency: New York plans to release nearly 170,000 documents on toxic air after 9/11, including what authorities knew and when. Nutrition & Lifestyle: A study flags a “physical activity paradox” in dementia risk, while another looks at how long gaps between meals affect older adults differently. Environmental Health Tool: LinusBio’s hair-based Traced test claims a month-long exposure profile for environmental elements.

Severe Asthma & Brain Changes: New research presented at the European Respiratory Society links severe type-2 asthma with subtle differences in brain structure, suggesting the condition may affect more than the lungs. GLP-1 & Mental Health: A large Swedish-data study reports lower psychiatric hospitalization rates in people with bipolar disorder when taking semaglutide (Ozempic/Wegovy), hinting at possible mental-health benefits. Dementia Prevention & Activity Context: A major analysis in The Lancet Public Health finds recreational movement and household chores may lower dementia risk, while physically demanding work and active commuting could raise it. Cancer Care in Sweden: Karolinska Institutet and partners receive a SEK 15 million donation to expand medical radiation science and precision radiation therapy capacity. Prostate Screening Upgrade: A Karolinska Institutet thesis examines how the Stockholm3 blood test performs across ethnic groups and compares it with other screening tools. Nutrition for Patients: Fresenius rolls out NutriChef, a real-food-based enteral nutrition concept, across six European markets including Sweden. Food Access Research: Daniel’s Table launches “Predictable Choice” with Boston University and a Swedish partner to study whether reducing uncertainty in food access improves health. Sweden Election & Healthcare: Sweden heads to a tight election where healthcare and the welfare state are central issues, with security concerns also shaping voter sentiment. Public Health & Safety Tech: Opsio, a Swedish AI firm, launches PrismIQ for automated visual inspection in India, aiming to reduce missed defects in manufacturing.

Dengue Drug Pipeline: WHO reviewed the global dengue drug pipeline and found six candidates worth further development, but only one has reached late-stage (Phase 3) trials—highlighting how few options are close to real-world use. Cancer Prevention Question: A growing debate asks whether removing fallopian tubes (salpingectomy) can lower ovarian cancer risk, especially for women at higher genetic risk. Women’s Health & Immunity: A new review reframes ovulation as an immune-guided process, describing how immune cells and timed molecular signals help remodel the follicle and trigger the corpus luteum. Sweden Election & Health Policy Context: Sweden’s 13 September vote is expected to shift less on broad direction but more on immigration and law-and-order—an angle that may shape future public health priorities. Animal Health Research: Swedish-led work suggests breeding poultry to shed less virus could reduce spread of Marek’s disease, pointing to flock-level protection beyond individual vaccination. Royal Health Update (Denmark): Queen Margrethe II is hospitalized with a blood clot and dehydration, with treatment and observation expected to continue.

Sweden Health Policy: Sweden’s new national obesity guidance for adults tightens eligibility for novel anti-obesity medicines, with doctors warning it could exclude people who still need treatment; the guidance uses higher BMI thresholds than the EMA-based FASS recommendations, sparking debate over prevention vs reimbursement. Cancer Care in Sweden: A Swedish prospective study reports five-year patient-reported quality of life after proton beam therapy for meningioma, offering long-term reassurance on lived outcomes. Mental Health Access: Estonia’s survey finds older adults are far more likely to get antidepressants than therapy, pointing to stigma and confusion in how people navigate care. Public Health & Safety: Sweden launches a new inquiry to strengthen gambling protections for children and young adults, focusing on marketing exposure and higher risk among boys and young men. Clinical Research (Global): A new head-to-head psoriasis/psoriatic arthritis trial discussion highlights how comparative efficacy data could shape payer coverage decisions—without forcing one-size-fits-all treatment. Toxic Exposure Warning: A toxics watchdog group warns about online sales of mercury-laced skin lighteners, urging platforms to block promotions.

Gut–Liver Breakthrough: A University of Gothenburg team reports a gut bacteria metabolite (imidazole propionate) linked to primary sclerosing cholangitis, with higher levels tied to worse survival and scarring in models—opening doors to future treatments that target the metabolite. Hidden Hormone Clue in Hypertension: Researchers used a wearable to spot hormone surges in primary aldosteronism that standard single blood tests can miss, suggesting some high blood pressure cases may be easier to diagnose with continuous monitoring. Meal Timing in Older Age: A Swedish study finds long gaps between meals are associated with faster development of chronic disease in people 60+, especially those 78+, challenging “fasting” advice drawn from younger groups. Cancer & Prevention Watch: New findings add to the debate on whether marijuana smoke raises lung cancer risk, while separate research highlights a shingles vaccine’s potential dementia-prevention effect. Rehab at Home: A review suggests game-based telerehabilitation for multiple sclerosis is safe and well liked, with the most consistent gains in balance and posture.

Meal Timing & Aging: A new Swedish study following nearly 3,000 people aged 60+ found that longer gaps between meals were linked to faster development of chronic diseases, with the clearest effect in those aged 78+. Sleep & Work Life: Research suggests how long people sleep at age 50 may predict how many months they’ll spend in paid work, with nine-plus hours tied to a shorter working life expectancy. Dementia Prevention Angle: A large study reports the shingles vaccine (Shingrix) is associated with a lower risk of dementia diagnosis over four years, adding to growing interest in vaccine-based prevention. AI Health Debate: UK experts criticized an AI sleep-cough approach promoted by a public health agency, warning that many conditions can cause night coughing and questioning what it would add for outbreak tracking. Sweden Student Permits: Sweden has published five conditions for foreign students seeking residence permits in 2026, including full-time admission, upfront tuition payment, passport validity, and health insurance/self-sufficiency requirements. Public Health & Food: A Swedish cohort study links higher processed meat intake with increased health risks, including stroke and cancer, and adds to concerns about long-term effects.

Dementia Prevention Breakthrough: A large study of 500,000 older adults reports the shingles vaccine (Shingrix) is linked to a 24% lower chance of being diagnosed with dementia over four years, adding momentum to vaccine-based prevention ideas. Older Adults & Food Timing: New Swedish-linked research suggests long gaps between meals may speed up chronic disease development in people aged 78+, raising questions about whether fasting advice from younger groups fits older bodies. Sweden Student Visas: Sweden has published five 2026 requirements for student residence permits, including full-time admission, upfront tuition payment, financial self-sufficiency, and health insurance. Postpartum Psychosis Genetics: A new study finds about half of postpartum psychosis risk is genetic, and points to shared biological pathways with schizophrenia and some autoimmune conditions. Diabetes & Menopause Care Attention: Coverage highlights severe menopause symptoms in women and the need for better recognition and support, while also flagging new research on diabetes treatment risks and heart effects. Public Health & Lifestyle: A Swedish cohort discussion links processed meat intake with higher stroke risk and broader health concerns, reinforcing calls to rethink lunchbox habits. Safety Watch: Sweden-adjacent readers also saw a reminder that health isn’t only clinical—long meal gaps and lifestyle choices can matter, just like injury risks in everyday life.

Postpartum Mental Health: A large genetics-focused study in Molecular Psychiatry finds about half the risk for postpartum psychosis is tied to genetic factors, including a gene linked to cholesterol production, pointing to shared biology with schizophrenia and some autoimmune conditions. Women’s Health & Cancer Prevention: A new overview highlights how existing vaccines (HPV and hepatitis B) already prevent cancers by blocking infection pathways, and notes a pipeline of next-gen cancer vaccines that could expand prevention over the next decade. Swedish Data on Heart Risk: A Swedish registry study of three million women links HPV infection with slightly higher odds of heart disease, adding to the growing picture of long-term health effects beyond cancer. Autoimmune Insights: Swedish-led research in The Journal of Clinical Investigation suggests autoimmune diseases cluster genetically by the organs they affect, rather than sharing one single genetic cause. Hip Fracture Outcomes: Swedish research in the British Journal of Anaesthesia reports education (via health literacy and support) is a key factor for survival after broken-hip surgery in seniors. Mental Health in Psychosis: A Swedish study finds people with psychotic spectrum disorders are less accurate at reading others’ emotions, with interpersonal aggression linked to worse emotion recognition. Health Policy Angle: NYC’s one-year moratorium on student-facing generative AI for grades up to eighth grade is framed as a potential global precedent for how schools handle AI and student wellbeing.

Hip fracture care in Sweden: A Swedish study of ~58,000 seniors found education level strongly linked to survival after broken-hip surgery—suggesting “health literacy” and better ability to follow recovery guidance may matter more than income or where people live. Cancer prevention: Researchers say the next decade could expand preventive cancer vaccines, building on proven shots like HPV and hepatitis B that stop infections that can later turn into cancer. MS treatment safety: Swedish-linked research reports a genetic “lymphocyte count” risk score tied to higher chances of moderate lymphopenia in people with multiple sclerosis treated with dimethyl fumarate. Joint replacement outcomes: A Swedish/UK trial in The Lancet found dual mobility hip implants cut postoperative hip dislocation risk by about 70% in patients aged 65+ with displaced femoral neck fractures. Digital health research: Karolinska Institutet and IVI strengthen collaboration on infectious disease and vaccine development, including HPV work and training. Gut health product move: Immuron’s Proibs digestive device gets a Sweden-to-U.S. distribution deal, driving a sharp stock jump.

Swedish Registry Health: A Swedish national registry study of ~3 million women links HPV infection to a slightly higher risk of new cardiovascular disease, with the biggest signal in the first year—researchers stress the absolute risk difference is small. Orthopaedic Care: A Swedish-led controlled trial in The Lancet reports dual mobility hip implants cut postoperative hip dislocation risk by about 70% in patients aged 65+ after displaced femoral neck fracture. MS Treatment Safety: Another Swedish-linked study finds common genetic variation tied to lymphocyte counts may help predict who is more likely to develop moderate lymphopenia on dimethyl fumarate in MS. Public Health Tech: In Congo’s Ebola response, Swedish non-profit Flowminder is using anonymised mobile phone movement data to help forecast where spread could reach next. Health & Policy Watch: YouTube says it will automate labels for undisclosed sponsored videos, shifting disclosure control from creators to machine detection. Infection Alert: ECDC reports rising cases of a rare sexually transmitted skin infection (“rain rot”/dermatophilosis) across several European countries, including Sweden.